MedTrace Logo

The Oslo Stan vs Lactate Observational Study

NCT04779294 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 694

Last updated 2023-12-04

No results posted yet for this study

Summary

The main aim of the study is to compare the clinical performance of two adjunctive methods to CTG in intrapartum fetal monitoring: FBS with measurement of scalp lactate and ST analysis of the fetal ECG.

Conditions

  • Fetal Monitoring

Interventions

DIAGNOSTIC_TEST

STAN ( St wave analysis) and fetal blood sample-lactate

The CTG will be analysed by an expert group additional to the standard procedure that have been done in Labour already. The STAN analysis will be decrypted/ demasked anonymously by the Company producing these machines.

Sponsors & Collaborators

  • Haukeland University Hospital

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Jacobsen F Anne Flem, MD, PhD · OUH

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-12-31
Completion
2023-10-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04779294 on ClinicalTrials.gov